Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06706557 | Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer(LEGO) | recruiting | — | 30 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06762483 | Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,(L2-268) | recruiting | — | 80 | European Institute of Oncology |
| 1 |
| Mar 24, 2026 |
| clinicaltrials |
| NCT07335081 | ctDNA in HER2+ EBC Neoadjuvant Treatment | recruiting | Phase 2 | 60 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT05245812 | Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy | recruiting | N/A | 90 | Deborah Farr, MDOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05748834 | Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer | recruiting | Phase 2 | 36 | SCRI Development Innovations, LLCOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06568705 | Hypofractionated Online Adaptive Radiotherapy of Breast Cancer | recruiting | Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07486089 | Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)(DUAL-NK-BC) | recruiting | Phase 1 / Phase 2 | 60 | Beijing BiotechINDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05404321 | Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment(TRIPLEX) | recruiting | — | 163 | Centre Francois BaclesseOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07227038 | Living Well With Advanced Breast Cancer | recruiting | — | 50 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07484087 | Ablation Compare With Surgery for Early Breast Cancer | recruiting | N/A | 264 | Peking University People's HospitalOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT05007379 | Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids(CARMA) | recruiting | — | 100 | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT05020574 | Microbiome and Association With Implant Infections | recruiting | Phase 2 | 200 | University of California, San FranciscoOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | recruiting | N/A | 800 | University of Southern CaliforniaOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06833853 | A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients(CTC-EXPRESS) | recruiting | — | 187 | Menarini Silicon Biosystems, INCINDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06900374 | Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients(RF-Vaginale) | recruiting | N/A | 75 | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07478900 | Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer(TUMS) | recruiting | N/A | 30 | All India Institute of Medical Sciences, BhubaneswarOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT04119024 | Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | recruiting | Phase 1 | 18 | Anusha KalbasiOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT05291507 | Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System(BreastMRgFUS) | recruiting | Early Phase 1 | 34 | University of UtahOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT06418204 | Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics(COSMIC) | recruiting | — | 2,000 | Wake Forest University Health SciencesOTHER | 2 | Mar 17, 2026 | clinicaltrials |
| NCT06908928 | A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs | recruiting | Phase 1 | 52 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Mar 17, 2026 | clinicaltrials |
| NCT06926075 | Early Phase Study of KESONOTIDE™in Participants With Solid Tumours(ADVICE) | recruiting | Phase 1 / Phase 2 | 80 | Filamon LTDINDUSTRY | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07478016 | EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients(EXIST) | recruiting | — | 200 | Thomas Jefferson UniversityOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT06555588 | Engage Psychosocial Intervention for Cancer Symptoms(Engage) | recruiting | N/A | 190 | Duke UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06610539 | PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients(MAGProm) | recruiting | — | 184 | Endomagnetics Ltd.INDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06767527 | AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer | recruiting | Phase 3 | 416 | AkesoINDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07474337 | The Effect of Mindfulness-Based Breathing Exercises on Symptom Control | recruiting | N/A | 72 | Firat UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06681233 | Feasibility Study of CBCT for IGRT in Cancer Patients | recruiting | N/A | 50 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07379918 | Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer(SiMoSein) | recruiting | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07469267 | Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases(RELAX) | recruiting | N/A | 1,608 | Fudan UniversityOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07469709 | A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks(PRO-ACTIVE) | recruiting | — | 850 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07471776 | Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer | recruiting | Phase 2 | 45 | Fudan UniversityOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT03909282 | Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma(NORDIS) | recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06053086 | SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology(SAHARA-04) | recruiting | N/A | 500 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06336928 | A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis | recruiting | — | 490 | University of Southern CaliforniaOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06349642 | Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform(ELEPHAS-04) | recruiting | — | 324 | Mayo ClinicOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06382818 | Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability(PROBA) | recruiting | N/A | 854 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07084571 | Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution(FORTITUDE) | recruiting | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07467330 | Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment | recruiting | Phase 3 | 258 | Fujian Cancer HospitalOTHER_GOV | 1 | Mar 12, 2026 | clinicaltrials |
| NCT05524584 | Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer | recruiting | Phase 2 | 20 | University of California, IrvineOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07219277 | Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening | recruiting | — | 2,000 | Syantra Inc.INDUSTRY | 3 | Mar 11, 2026 | clinicaltrials |
| NCT07447440 | Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases(RESOLBE) | recruiting | — | 60 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07464457 | Effects of Neoadjuvant Prehabilitation on Post-Interventional Physical and Psychological Outcomes in Oncology Patients With Solid Tumors(NEOPRO-SIT) | recruiting | N/A | 125 | Priv.-Doz. Dr. med. Philipp LenzOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05483283 | Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care | recruiting | N/A | 600 | University of Illinois at ChicagoOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06954623 | Partial Breast Re-irradiation for Breast Cancer(BREAST) | recruiting | N/A | 20 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06704659 | Study on Recurrent Breast Cancer and Repeated Radiation Therapy(RAY-no-BAN) | recruiting | N/A | 60 | Turku University HospitalOTHER_GOV | 1 | Mar 9, 2026 | clinicaltrials |
| NCT06765590 | Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer | recruiting | N/A | 24 | Sichuan Huiyu Pharmaceutical Co., LtdINDUSTRY | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07457359 | Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer(NEOTRIO-2) | recruiting | Phase 2 | 18 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07459062 | Spectral Cancer Tissue Recognition - I(SPCTR-I) | recruiting | — | 100 | SPCTRINDUSTRY | 1 | Mar 9, 2026 | clinicaltrials |
| NCT06039644 | To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer | recruiting | N/A | 100 | GenMont Biotech IncorporationINDUSTRY | 1 | Mar 6, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Mar 24, 2026source: clinicaltrials